Evaluation of relative biological effectiveness of 225Ac and its decay daughters with Monte Carlo track structure simulations

Abstract Background 225Ac is a radionuclide that can be utilized in targeted alpha therapy (TAT). To accurately assess the absorbed dose and radiation effects in TAT, it is necessary to calculate the relative biological effectiveness (RBE). This study aims to calculate the RBE of 225Ac and its decay...

Full description

Saved in:
Bibliographic Details
Main Authors: Ziyi Hu, Shuiyin Qu, Hongming Liu, Yunhao Zhang, Shuchang Yan, Ankang Hu, Rui Qiu, Zhen Wu, Hui Zhang, Junli Li
Format: Article
Language:English
Published: SpringerOpen 2025-07-01
Series:EJNMMI Physics
Subjects:
Online Access:https://doi.org/10.1186/s40658-025-00765-0
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background 225Ac is a radionuclide that can be utilized in targeted alpha therapy (TAT). To accurately assess the absorbed dose and radiation effects in TAT, it is necessary to calculate the relative biological effectiveness (RBE). This study aims to calculate the RBE of 225Ac and its decay daughters with a Monte Carlo method. Methods This study employed the NASIC program to perform microdosimetric simulations of 177Lu, 225Ac and its decay daughters in a cell population. Absorbed doses and lineal energy spectra in the cell nucleus were obtained for eight different radionuclides, three different cells, and six radionuclide spatial distribution. The RBE was then calculated using a modified stochastic microdosimetric kinetic model (mSMKM). Results The results indicated that variations in radionuclide distribution had a greater impact on the absorbed dose in the cell nucleus. Taking 225Ac in V79 cells as an example, the maximum differences in RBE and absorbed dose due to different distributions were 10% and 80%, respectively. For V79 cells, with a uniform distribution of radionuclides within the cell, the RBEM, i.e. RBE at zero dose, of 225Ac was 6.91 ± 0.04. In its decay chain, the RBEM was 6.81 ± 0.04 for 221Fr, 6.67 ± 0.02 for 217At, 6.43 ± 0.05 for 213Po, and 5.91 ± 0.09 for 213Bi. The β-emitting radionuclides 209Tl and 209Pb had RBE close to 1. Conclusions RBE of each radionuclide in 225Ac decay chain was evaluated separately with a Monte Carlo track structure code. The RBE of 225Ac and its decay daughters was found to be influenced by absorbed dose, radionuclide distribution, and cell type. The intracellular distribution of radionuclides had influence on the magnitude of RBE, but was less significant than its impact on the absorbed dose. Additionally, there were differences in the RBE of each radionuclide in the 225Ac decay chain that could not be neglected. These findings contribute to the calculation of RBE-weighted doses and the assessment of biological effects in 225Ac-based TAT.
ISSN:2197-7364